RFA-NS-25-023-Full-Announcement.html

This document is a Request for Application (RFA) for the HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) federal grant opportunity.

The grant is funded by the Department of Health and Human Services National Institutes of Health, with the goal of encouraging initial translational efforts to support a drug discovery program and advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program. The scope is focused on development of assays, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents. Eligible applicants include state governments, for-profit organizations, nonprofits, small businesses, and higher education institutions among others. The grant provides funding through R61/R33 mechanisms. Key federal grant programs under which this opportunity is assigned include Cancer Cause and Prevention Research, Arthritis, Musculoskeletal and Skin Diseases Research, and Extramural Research Programs in the Neurosciences and Neurological Disorders.